Display options
Cite
Bener A, Zirie M, Al-Hamaq A, et al. Impact of the Pro12Ala polymorphism of the PPARγ2 gene on diabetes and obesity in a highly consanguineous population. Indian J Endocrinol Metab. 2015;19(1):77-83doi: 10.4103/2230-8210.131766.
Bener, A., Zirie, M., Al-Hamaq, A., Nawaz, Z., Samson, N., & Mohammad, R. (2015). Impact of the Pro12Ala polymorphism of the PPARγ2 gene on diabetes and obesity in a highly consanguineous population. Indian journal of endocrinology and metabolism, 19(1), 77-83. https://doi.org/10.4103/2230-8210.131766
Bener, Abdulbari, et al. "Impact of the Pro12Ala polymorphism of the PPARγ2 gene on diabetes and obesity in a highly consanguineous population." Indian journal of endocrinology and metabolism vol. 19,1 (2015): 77-83. doi: https://doi.org/10.4103/2230-8210.131766
Bener A, Zirie M, Al-Hamaq A, Nawaz Z, Samson N, Mohammad R. Impact of the Pro12Ala polymorphism of the PPARγ2 gene on diabetes and obesity in a highly consanguineous population. Indian J Endocrinol Metab. 2015 Jan-Feb;19(1):77-83. doi: 10.4103/2230-8210.131766. PMID: 25593831; PMCID: PMC4287785.
Copy Download .nbib Format: NLM
Share it on

Indian J Endocrinol Metab. 2015 Jan-Feb;19(1):77-83. doi: 10.4103/2230-8210.131766.

Impact of the Pro12Ala polymorphism of the PPARγ2 gene on diabetes and obesity in a highly consanguineous population.

Indian journal of endocrinology and metabolism

Abdulbari Bener, M Zirie, Aoaa Al-Hamaq, Z Nawaz, N Samson, R Mohammad

Affiliations

  1. Department of Medical Statistics and Epidemiology, Hamad Medical Corporation, Doha, Qatar ; Department of Evidence for Population Health Unit, School of Epidemiology and Health Sciences, The University of Manchester, Manchester, UK.
  2. Department of Endocrinology, Hamad Medical Corporation, Hamad General Hospital, Qatar.
  3. Qatar Diabetic Association and Qatar Foundation, Doha, Qatar.
  4. Department of Laboratory Medicine and Pathology, Cytogenetics and Molecular Cytogenetics Laboratory, Hamad Medical Corporation, Qatar.
  5. Department of Medical Statistics and Epidemiology, Hamad Medical Corporation, Doha, Qatar.
  6. Department of Oncology, Wayne State University, School of medicine, Michigan, USA, and Department of Medicine, Hamad Medical Corporation, State of Qatar.

PMID: 25593831 PMCID: PMC4287785 DOI: 10.4103/2230-8210.131766

Abstract

BACKGROUND: The peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor subfamily of transcription factors. It has been reported that they play important roles in obesity and the development of type 2 diabetes mellitus (T2DM).

MATERIALS AND METHODS: This case-control study was carried out among 764 Qatari patients with diabetes and 764 healthy subjects above 20 years of age at Primary Healthcare Clinics (PHCs) from January 2011 to December 2012. Face-to-face interviews were based on a questionnaire that included variables such as age, sex, sociodemographic status, body mass index (BMI) and other clinical parameters. The Pro12Ala in the PPARγ2 gene was detected on the LightCycler using two specific probes. Univariate and multivariate statistical analysis were performed.

RESULTS: The study revealed that in the diabetes group, Pro/(10.2% vs 9.4%; P = 0.606) and Ala/Ala (1.4% vs 0.9%; P = 0.343) were higher than in controls, whereas Pro/Pro (88.4% vs 89.7%;P = 0.413) was lower in diabetes patients, but no significant difference was observed among the genotype groups. In obese patients with diabetes, Pro/Pro (89% vs 89.9%;P = 0.792) and Pro/Ala (8.9% vs 10.1%;P = 0.671) were lower than in obese healthy subjects. No homozygous Ala/Ala was found in obese healthy subjects, whereas 6 Ala/Ala homozygotes were in obese diabetes group. But in diabetes group, obese patients had higher homozygous of Pro/Pro (89.3% vs 87.8%;P = 0.523) and Ala/Ala (1.8% vs 1.2%;P = 0.771) compared to non-obese patients.

CONCLUSION: The current study did not reveal an association between the Pro12Ala polymorphism of the PPAR γ2 gene and type 2 diabetes (T2D) in Qatari's population.

Keywords: Allele frequency; PPARγ2 gene; Pro12Ala polymorphism; consanguinity; diabetes mellitus; obesity

References

  1. Metab Syndr Relat Disord. 2009 Oct;7(5):453-8 - PubMed
  2. Biochem Biophys Res Commun. 1999 Jan 19;254(2):450-3 - PubMed
  3. Acta Diabetol. 2008 Mar;45(1):15-21 - PubMed
  4. Biochem Biophys Res Commun. 2000 Apr 29;271(1):212-6 - PubMed
  5. Ann N Y Acad Sci. 2002 Jun;967:265-73 - PubMed
  6. Nat Genet. 2000 Sep;26(1):76-80 - PubMed
  7. Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):465-9 - PubMed
  8. Diabetes. 2001 Apr;50(4):891-4 - PubMed
  9. Exp Clin Endocrinol Diabetes. 2002 Apr;110(2):60-6 - PubMed
  10. Diabetes. 2002 Aug;51(8):2341-7 - PubMed
  11. Diabetes. 1998 Apr;47(4):507-14 - PubMed
  12. BMC Med Genet. 2005 Mar 22;6:11 - PubMed
  13. Diabetes Care. 2006 Jan;29(1):171-2 - PubMed
  14. J Hypertens. 2003 Nov;21(11):1983-92 - PubMed

Publication Types